carbogen has been researched along with Atheroma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baganha, F; de Vries, MR; Parma, L; Peters, HAB; Quax, PHA; Sluimer, JC | 1 |
| Biessen, EA; Cleutjens, JP; Daemen, MJ; Demandt, JA; Donners, MM; Dubois, LJ; Fisher, EA; Gijbels, MJ; Haenen, GR; Heemskerk, JW; Janssen, A; Janssen, BJ; Jeurissen, M; Lambin, P; Mallat, Z; Marsch, E; Meex, SJ; Schalkwijk, CG; Sluimer, JC; Theelen, TL; van Gink, M; Verjans, R | 1 |
2 other study(ies) available for carbogen and Atheroma
| Article | Year |
|---|---|
Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice.
Topics: Animals; Apolipoprotein E3; Apoptosis; Atherosclerosis; Blood Vessel Prosthesis; Carbon Dioxide; DNA Damage; Hemorrhage; Hypoxia; Inflammation; Macrophages; Male; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Oxygen; Plaque, Atherosclerotic; Reactive Oxygen Species; Vascular Patency; Veins | 2020 |
Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
Topics: Animals; Apoptosis; c-Mer Tyrosine Kinase; Carbon Dioxide; CD36 Antigens; Humans; Hypoxia; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Oxygen; Phagocytosis; Plaque, Atherosclerotic; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Receptors, LDL | 2014 |